Theranostics Beyond Oncology: Emerging Applications
Journal of Nuclear Medicine Technology · 2025-12 · 53 (Supplement 1) · 141S-143S
DOI: 10.2967/jnmt.125.271192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine Technology, online erschienen am 04.12.2025. Verfasst von Sara L Johnson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gurnick Academy of Medical Arts, Concord, California sajohnson@gurnick.edu. Hauptthemen laut MEDLINE: Theranostic Nanomedicine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Theranostics, the combination of targeted diagnostic imaging and treatment, is rapidly expanding its role beyond oncology into various noncancerous diseases. Recent advances in radiopharmaceuticals, molecular imaging, and nanoparticle-based technologies are enabling the detection and treatment of conditions in cardiology, neurology, autoimmune, and bone marrow disorders. These innovations include targeted imaging and therapy for atherosclerosis and cardiac amyloidosis, as well as neurodegenerative disorders such as Alzheimer disease. Additionally, they encompass biomarkers such as fibroblast activation protein inhibitor and radiolabeled glucocorticoids in autoimmune and inflammatory diseases, as well as the selective ablation of diseased tissue in bone marrow conditioning. Despite the promise of these developments, several challenges must be considered, including the integration of theranostic strategies into standard practice and establishing their efficacy through robust clinical trials. This review examines the emerging nononcologic applications of theranostics, highlighting current research and future potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gurnick Academy of Medical Arts, Concord, California sajohnson@gurnick.edu.
- Gurnick Academy of Medical Arts, Concord, California.
Zitieren
APA
Johnson, S. L., Gibbons, S. R., & Nielsen, C. J. (2025). Theranostics Beyond Oncology: Emerging Applications. Journal of Nuclear Medicine Technology, 53(Supplement 1), 141S-143S. https://doi.org/10.2967/jnmt.125.271192
Vancouver
Johnson SL, Gibbons SR, Nielsen CJ. Theranostics Beyond Oncology: Emerging Applications. Journal of Nuclear Medicine Technology. 2025;53(Supplement 1):141S-143S. doi:10.2967/jnmt.125.271192
BibTeX
@article{Johnson2025,
author = {Johnson, Sara L and Gibbons, Sarah R and Nielsen, Cybil J},
title = {Theranostics Beyond Oncology: Emerging Applications},
journal = {Journal of Nuclear Medicine Technology},
year = {2025},
volume = {53},
number = {Supplement 1},
pages = {141S--143S},
doi = {10.2967/jnmt.125.271192}
}
EUVIMED